To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CDC25ATABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
154 supporting clones for gene CDC25A back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB071273 testis .a 1 to 307 2 to 308   tiling clone, capped   307/307
(100 %)
0 diff
(100 %id)
M81933   .a 7 to 2420 1 to 2418 E6S P8A H9P R12L L14F ...     2418/2419
(99 %)
20 diff
(99.2 %id)
AU098998   .a 25 to 324 1 to 300       300/300
(100 %)
12 diff
(96.0 %id)
BM465140 eye, retinoblastoma .a 32 to 360 168 to 496       329/1478
(22 %)
6 diff
(99.6 %id)
CN263055 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 36 to 537 1 to 502       502/502
(100 %)
4 diff
(99.3 %id)
BU169565 embryonal carcinoma, cell line, testis .a 48 to 397 1 to 350       350/1159
(30 %)
2 diff
(99.9 %id)
AL556900 placenta .a 50 to 996 1 to 944       944/944
(100 %)
3 diff
(99.7 %id)
BM459239 lymph, lymphoma, cell line .a 50 to 402 1 to 353       353/1483
(23 %)
2 diff
(99.9 %id)
BE796962 lung, small cell carcinoma .a 60 to 783 1 to 726       726/895
(81 %)
7 diff
(99.3 %id)
BC007401 Lymph, Burkitt lymphoma .a 95 to 2603 1 to 2509 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2509/2509
(100 %)
0 diff
(100 %id)
BC018642 Lymph, Burkitt lymphoma .a 95 to 2603 1 to 2509   available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2509/2509
(100 %)
0 diff
(100 %id)
NM_001789.2   .a 95 to 3800 1 to 3706 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3706/3706
(100 %)
0 diff
(100 %id)
BE513704 Burkitt lymphoma, lymph .a 109 to 562 1 to 450       450/450
(100 %)
8 diff
(98.3 %id)
BE267837 Burkitt lymphoma, lymph .a 114 to 716 1 to 610       610/610
(100 %)
7 diff
(98.9 %id)
BE513548 Burkitt lymphoma, lymph .a 114 to 783 1 to 690       690/752
(91 %)
28 diff
(96.3 %id)
BE561237 Burkitt lymphoma, lymph .a 114 to 878 1 to 763       763/763
(100 %)
12 diff
(98.5 %id)
BE560148 Burkitt lymphoma, lymph .a 114 to 790 1 to 695       676/740
(91 %)
35 diff
(95.3 %id)
BX383387   .a 190 to 1067 1 to 877       877/880
(99 %)
2 diff
(99.8 %id)
AK290554 heart .a 420 to 2231 1 to 1812 L316F     1812/1812
(100 %)
3 diff
(99.9 %id)
DA534882 heart .a 421 to 963 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BP246503 Kidney .a 423 to 1009 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
BP249012 Kidney .a 423 to 1004 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BG470818 eye, retinoblastoma .a 425 to 1139 1 to 714       714/722
(98 %)
6 diff
(99.2 %id)
TI_1948136771   .a 458 to 1106 128 to 781       654/1429
(45 %)
30 diff
(98.0 %id)
TI_1948136772   .a 458 to 1215 128 to 888       761/1251
(60 %)
20 diff
(98.5 %id)
TI_1948137117   .a 458 to 1007 131 to 681       551/1326
(41 %)
8 diff
(99.4 %id)
TI_1948137454   .a 458 to 1141 129 to 812       684/1307
(52 %)
14 diff
(99.0 %id)
TI_1948137455   .a 458 to 1214 130 to 899       768/1252
(61 %)
24 diff
(98.1 %id)
TI_1948137804   .a 458 to 1141 129 to 814       686/1052
(65 %)
24 diff
(97.8 %id)
CV026535 mixed .a 459 to 1043 1 to 585       585/596
(98 %)
3 diff
(99.5 %id)
CD612825   .a 474 to 935 1 to 462       462/463
(99 %)
1 diff
(99.8 %id)
CD612826   .a 474 to 935 462 to 1       462/462
(100 %)
0 diff
(100 %id)
CD612831   .a 632 to 935 1 to 304       304/305
(99 %)
1 diff
(99.7 %id)
CD612832   .a 632 to 935 303 to 1       303/303
(100 %)
1 diff
(99.7 %id)
CD612835   .a 632 to 935 1 to 304       304/305
(99 %)
1 diff
(99.7 %id)
CD612836   .a 632 to 928 294 to 1       294/294
(100 %)
3 diff
(99.0 %id)
BG825274 muscle, rhabdomyosarcoma .a 683 to 1433 1 to 751       751/751
(100 %)
4 diff
(99.5 %id)
CN263057 embryonic stem cells, cell lines H1, H7, andH9 .a 706 to 1169 1 to 466       466/466
(100 %)
2 diff
(99.6 %id)
BX328360   .a 711 to 1615 1 to 907       907/907
(100 %)
9 diff
(99.1 %id)
BG818562 anaplastic oligodendroglioma with 1p/19qloss, brain .a 741 to 1517 1 to 779       779/779
(100 %)
2 diff
(99.8 %id)
CV815472 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 787 to 1489 1 to 703       703/703
(100 %)
0 diff
(100 %id)
BQ437628 melanotic melanoma, skin .a 867 to 1724 9 to 871       863/913
(94 %)
26 diff
(97.2 %id)
AL579018 placenta .a 2793 to 3767 968 to 1   tiling clone,   968/968
(100 %)
59 diff
(94.0 %id)
BX383386   .a 2816 to 3770 954 to 1   tiling clone,   954/954
(100 %)
4 diff
(99.6 %id)
NM_201567.1   .b 1 to 3586 1 to 3586 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3586/3586
(100 %)
0 diff
(100 %id)
AY137580   .b 365 to 1819 1 to 1455 exact tiling clone,   1455/1455
(100 %)
0 diff
(100 %id)
AF277722   .b 473 to 946 1 to 474       474/474
(100 %)
1 diff
(99.8 %id)
CN263054 embryonic stem cells, cell lines H1, H7, andH9 .b 552 to 1036 1 to 485       485/485
(100 %)
1 diff
(99.8 %id)
BE883719 leiomyosarcoma, uterus .b 588 to 1228 1 to 656       656/656
(100 %)
21 diff
(96.8 %id)
BX333048 Neuroblastoma Cot 25-normalized .b 770 to 1569 1 to 801       801/901
(88 %)
8 diff
(99.2 %id)
TI_1948137457   .b 792 to 1818 1160 to 128       1033/1289
(80 %)
21 diff
(98.4 %id)
BG899526 cartilage .b 824 to 1248 83 to 506       424/438
(96 %)
7 diff
(98.5 %id)
BI092733 cervix .b 880 to 1644 1 to 764       762/764
(99 %)
6 diff
(99.3 %id)
BX390096 Neuroblastoma Cot 10-normalized .b 922 to 1274 1 to 357       357/632
(56 %)
10 diff
(98.5 %id)
TI_1948136774   .b 1001 to 1818 948 to 130       819/1299
(63 %)
18 diff
(98.7 %id)
TI_1948137806   .b 1004 to 1818 951 to 130       820/1344
(61 %)
26 diff
(98.1 %id)
DA714056   .b 1034 to 1591 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BQ879043 ductal carcinoma, cell line, Pancreas .b 1082 to 1626 1 to 551       551/1108
(49 %)
12 diff
(99.0 %id)
BF204165 muscle, rhabdomyosarcoma .b 1136 to 1909 1 to 758       758/898
(84 %)
32 diff
(96.5 %id)
DA748923   .b 1161 to 1738 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
AA248514   .b 1178 to 1457 1 to 278       278/278
(100 %)
5 diff
(98.3 %id)
TI_1948137456   .b 1202 to 1818 787 to 165   AAA   623/1105
(56 %)
15 diff
(98.7 %id)
CN263056 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1209 to 1782 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
BM466197 embryonal carcinoma, cell line, testis .b 1280 to 2099 1 to 820       820/1110
(73 %)
7 diff
(99.4 %id)
EH351903   .b 1287 to 1374 1 to 88       88/88
(100 %)
0 diff
(100 %id)
TI_1948136773   .b 1339 to 1818 540 to 60       481/1027
(46 %)
14 diff
(98.7 %id)
BI114213 muscle, rhabdomyosarcoma .b 1340 to 1958 1 to 617       617/778
(79 %)
13 diff
(98.4 %id)
BM755404 stomach .b 1349 to 1866 1 to 518       518/518
(100 %)
1 diff
(99.9 %id)
BF968769 adrenal cortex carcinoma, cell line, adrenal gland .b 1381 to 2169 1 to 786       786/931
(84 %)
11 diff
(98.9 %id)
BE781399 eye, retinoblastoma .b 1435 to 2193 1 to 757       757/779
(97 %)
17 diff
(97.9 %id)
BQ932604 leiomyosarcoma, uterus .b 1507 to 2491 24 to 1015       992/1044
(95 %)
57 diff
(94.6 %id)
BG424887 Kidney, renal cell adenocarcinoma .b 1535 to 2193 1 to 656       654/663
(98 %)
17 diff
(97.5 %id)
BG258336 embryonal carcinoma, cell line, testis .b 1580 to 2278 1 to 707       707/1003
(70 %)
22 diff
(97.9 %id)
BG258267 embryonal carcinoma, cell line, testis .b 1580 to 2282 1 to 703       703/999
(70 %)
33 diff
(96.7 %id)
CF145967 CNCAP(3)T-225 cell line, Prostate .b 1624 to 2107 8 to 491       484/491
(98 %)
6 diff
(98.8 %id)
TI_154178305   .b 1624 to 2165 81 to 622       542/543
(99 %)
3 diff
(99.5 %id)
BX114416 liver and spleen .b 1626 to 2315 1 to 690   tiling clone,   690/690
(100 %)
0 diff
(100 %id)
BM715615 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 1669 to 2382 1 to 709       709/709
(100 %)
4 diff
(99.5 %id)
AI671851 pooled germ cell tumors .b 1748 to 2389 640 to 1       640/640
(100 %)
3 diff
(99.6 %id)
R09062 liver and spleen .b 1781 to 2117 1 to 344   fully sequenced,   344/344
(100 %)
10 diff
(97.1 %id)
H59306 liver and spleen .b 1781 to 2143 1 to 371   fully sequenced,   371/371
(100 %)
8 diff
(97.9 %id)
BG280796 melanotic melanoma, skin .b 1884 to 2125 1 to 242       242/242
(100 %)
2 diff
(99.2 %id)
BG333888 melanotic melanoma, skin .b 1884 to 2125 1 to 241       241/241
(100 %)
2 diff
(99.2 %id)
BE384572 melanotic melanoma, skin .b 1899 to 2105 1 to 208       208/208
(100 %)
6 diff
(97.2 %id)
BE409135 choriocarcinoma, placenta .b 1905 to 2105 1 to 201       201/201
(100 %)
0 diff
(100 %id)
BM839469 Ascites, stomach .b 1918 to 2338 1 to 421       421/421
(100 %)
1 diff
(99.8 %id)
BF221494 pooled germ cell tumors .b 1960 to 2389 430 to 1       430/430
(100 %)
0 diff
(100 %id)
BF973002 leiomyosarcoma cell line, uterus .b 1962 to 2125 1 to 163       163/163
(100 %)
2 diff
(98.8 %id)
AI825764 pooled germ cell tumors .b 1997 to 2389 395 to 1       395/395
(100 %)
2 diff
(99.5 %id)
AI468542 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2008 to 2389 383 to 1       383/383
(100 %)
3 diff
(99.3 %id)
AW265081 endometrioid ovarian metastasis, ovary .b 2026 to 2389 385 to 22   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 364/364
(100 %)
27 diff
(92.6 %id)
T90115 liver and spleen .b 2035 to 2329 297 to 1       297/301
(98 %)
2 diff
(99.4 %id)
BG940631 blood .b 2037 to 2373 1 to 337       337/337
(100 %)
1 diff
(99.8 %id)
BX392016   .b 2054 to 2966 919 to 1   tiling clone,   919/919
(100 %)
9 diff
(99.1 %id)
CX760665 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 2082 to 2845 1 to 762     Submitted on the opposite strand 762/762
(100 %)
4 diff
(99.5 %id)
R09063 liver and spleen .b 2087 to 2379 299 to 1   fully sequenced,   299/299
(100 %)
10 diff
(96.7 %id)
H59260 liver and spleen .b 2113 to 2393 286 to 1   fully sequenced,   286/286
(100 %)
7 diff
(97.6 %id)
BE884069 leiomyosarcoma, uterus .b 2220 to 2788 1 to 574       574/712
(80 %)
7 diff
(99.1 %id)
BE814195 breast_normal .b 2221 to 2356 9 to 143       135/149
(90 %)
2 diff
(98.7 %id)
BE926858 breast .b 2239 to 2410 176 to 1       176/210
(83 %)
9 diff
(95.8 %id)
AA403280   .b 2294 to 2722 1 to 429       429/429
(100 %)
1 diff
(99.8 %id)
BF221662 pooled .b 2297 to 2666 1 to 370     Submitted on the opposite strand 370/370
(100 %)
3 diff
(99.2 %id)
BQ651098 hepatocellular carcinoma, cell line, Liver .b 2366 to 3153 1 to 797       797/911
(87 %)
31 diff
(96.6 %id)
BQ644714 hepatocellular carcinoma, cell line, Liver .b 2367 to 3160 1 to 801       801/953
(84 %)
46 diff
(95.2 %id)
BI261494 lymph, lymphoma, cell line .b 2388 to 3062 1 to 692   fully sequenced,   692/692
(100 %)
50 diff
(92.8 %id)
BQ065019 lymph, lymphoma, cell line .b 2390 to 3310 31 to 969       939/1008
(93 %)
29 diff
(97.2 %id)
BX343136   .b 2391 to 3526 1134 to 24       1111/1140
(97 %)
0 diff
(100 %id)
BE545403 cervical carcinoma cell line, cervix .b 2516 to 3286 1 to 778       778/844
(92 %)
40 diff
(95.3 %id)
BX333047 Neuroblastoma Cot 25-normalized .b 2571 to 3531 952 to 1       952/1012
(94 %)
32 diff
(96.9 %id)
BX401630   .b 2571 to 3553 972 to 1       972/999
(97 %)
30 diff
(97.0 %id)
BY994421   .b 2649 to 3312 29 to 692       664/692
(95 %)
6 diff
(99.2 %id)
BQ883064 brain, neuroblastoma, cell line .b 2781 to 3585 1 to 808   tiling clone,   808/812
(99 %)
5 diff
(99.4 %id)
BQ059789 lymph, lymphoma, cell line .b 2793 to 3549 1 to 762       762/949
(80 %)
13 diff
(98.7 %id)
BQ065803 lymph, lymphoma, cell line .b 2793 to 3584 1 to 798       798/1051
(75 %)
22 diff
(98.0 %id)
AA913262 pooled .b 2816 to 3039 1 to 222     Submitted on the opposite strand 222/229
(96 %)
5 diff
(97.9 %id)
TI_149289671   .b 2827 to 3584 867 to 109   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 759/982
(77 %)
8 diff
(99.2 %id)
BU631902 cell lines, Chondrosarcoma .b 2920 to 3584 682 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 664/664
(100 %)
1 diff
(99.9 %id)
BM971031 lung .b 2960 to 3584 643 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 625/625
(100 %)
0 diff
(100 %id)
AA341262 Kidney .b 3017 to 3353 1 to 338       338/339
(99 %)
3 diff
(99.2 %id)
BI262114 lymph, lymphoma, cell line .b 3024 to 3536 518 to 1   fully sequenced,   518/518
(100 %)
6 diff
(98.9 %id)
BU565875 mixed (pool of 40 RNAs) .b 3035 to 3584 1 to 550       550/550
(100 %)
2 diff
(99.7 %id)
BU149531 ductal carcinoma, cell line, Pancreas .b 3084 to 3584 1 to 501       501/501
(100 %)
0 diff
(100 %id)
BQ689872 ductal carcinoma, cell line, Pancreas .b 3084 to 3584 1 to 501   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 501/501
(100 %)
0 diff
(100 %id)
AI671182 pooled germ cell tumors .b 3095 to 3584 490 to 1       490/490
(100 %)
0 diff
(100 %id)
AI343459 colon, colon tumor, RER+ .b 3106 to 3586 493 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 482/482
(100 %)
1 diff
(99.8 %id)
AA082291 heart .b 3124 to 3583 1 to 448       448/448
(100 %)
14 diff
(96.9 %id)
DB518618 testis .b 3126 to 3586 1 to 461   tiling clone, AAA Submitted on the opposite strand 461/461
(100 %)
0 diff
(100 %id)
AI917350 pooled germ cell tumors .b 3135 to 3586 463 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 452/452
(100 %)
0 diff
(100 %id)
AW235354 pooled germ cell tumors .b 3145 to 3584 440 to 1       440/440
(100 %)
0 diff
(100 %id)
AI985626 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 3209 to 3585 385 to 9       377/385
(97 %)
0 diff
(100 %id)
AA648922 germinal center B cell .b 3219 to 3584 391 to 26   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 366/366
(100 %)
0 diff
(100 %id)
AI857422 anaplastic oligodendroglioma, brain .b 3223 to 3586 364 to 1       364/364
(100 %)
3 diff
(99.2 %id)
BG940632 blood .b 3253 to 3585 362 to 30       333/362
(91 %)
0 diff
(100 %id)
AW139217   .b 3275 to 3584 327 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 310/310
(100 %)
0 diff
(100 %id)
AI800535 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3307 to 3584 291 to 14   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 278/278
(100 %)
0 diff
(100 %id)
BE743496 adenocarcinoma cell line, ovary .c 1 to 777 1 to 777 Q30R P31A V32R V33R K34E ... tiling clone,   777/935
(83 %)
14 diff
(98.6 %id)
CD612834   .c 32 to 488 457 to 1       457/457
(100 %)
1 diff
(99.8 %id)
CD612828   .c 44 to 488 444 to 1       444/444
(100 %)
5 diff
(98.9 %id)
CD612829   .c 44 to 489 1 to 446       446/448
(99 %)
5 diff
(98.9 %id)
CD612830   .c 44 to 492 449 to 1       449/449
(100 %)
5 diff
(98.9 %id)
CD612837   .c 44 to 493 1 to 452       452/454
(99 %)
11 diff
(97.6 %id)
CD612838   .c 44 to 486 442 to 1       442/442
(100 %)
2 diff
(99.6 %id)
CD612839   .c 44 to 493 1 to 453       453/454
(99 %)
6 diff
(98.7 %id)
CD612840   .c 44 to 490 447 to 1   tiling clone,   447/447
(100 %)
1 diff
(99.8 %id)
CD612827   .c 47 to 492 1 to 446       446/447
(99 %)
8 diff
(98.3 %id)
AL705968 human skeletal muscle .d 1 to 767 1 to 770 L162F N163E G164W K165Q F166V ... tiling clone,   769/770
(99 %)
6 diff
(99.3 %id)
DR002405 fetal brain .e 1 to 531 1 to 532 G2E S3G E12X G93V F94S ... tiling clone,   532/533
(99 %)
13 diff
(97.6 %id)
DB453138 testis .f 1 to 498 1 to 498   tiling clone,   498/498
(100 %)
5 diff
(99.0 %id)
BM450524 eye, retinoblastoma .f 263 to 852 1 to 593   tiling clone,   591/1049
(56 %)
9 diff
(99.2 %id)
BG392509 embryonal carcinoma, cell line, testis .f 266 to 980 1 to 704   tiling clone,   704/706
(99 %)
25 diff
(96.5 %id)
BG395319 eye, retinoblastoma .f 278 to 995 1 to 727 H9K R10Q R11T R12A L13C ... tiling clone,   727/946
(76 %)
36 diff
(96.2 %id)
DB305143 brain Gene CDC25A, variant not shown         This clone was ignored    
DA224528 brain Gene CDC25A, variant not shown       capped This clone was ignored    
AL560704 B cells from Burkitt lymphoma Gene CDC25A, variant not shown         Suspected internal deletion, this clone was ignored    
AL582113 B cells from Burkitt lymphoma Gene CDC25A, variant not shown         Suspected internal deletion, this clone was ignored    
BX343137   Gene CDC25A, variant not shown         Suspected internal deletion, this clone was ignored    
AI656134 pooled germ cell tumors Gene CDC25A, variant not shown         This clone was ignored    
AI652585 pooled germ cell tumors Gene CDC25A, variant not shown         This clone was ignored    
AW590754 pooled germ cell tumors Gene CDC25A, variant not shown         This clone was ignored    
BE298834 muscle, rhabdomyosarcoma Gene CDC25A, variant not shown         This clone was ignored    
BE299022 muscle, rhabdomyosarcoma Gene CDC25A, variant not shown         This clone was ignored    
BE294109 muscle, rhabdomyosarcoma Gene CDC25A, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI